Sedation Clinical Trial
-to determine if propofol sedation leads to shorter recovery times compared to traditional sedation using midazolam plus meperidine
Colonoscopy is an important diagnostic and therapeutic procedure. It is an invasive
procedure, not well tolerated by most patients if performed without sedation. There is
considerable variability in the practice of sedation for endoscopic procedures worldwide.
There are some centers which perform a significant proportion of gastroscopies and
colonoscopies without sedation. On the other hand, general anesthesia is given to more than
90% of patients undergoing colonoscopy in France. Most centers do use conscious sedation,
usually in the form of benzodiazepines and/or narcotics, with propofol sedation reserved for
difficult cases. Benzodiazepines and narcotics are effective and safe. However, the onset of
sedation can be delayed, and in some patients conscious sedation is inadequate, resulting in
a poor experience with the procedure. Moreover, there are significant post-sedation side
effects, such as nausea, vomiting, and prolonged recovery period. This can substantially
increase procedure costs due to the need for prolonged monitoring after endoscopy.
Propofol, a general anesthetic agent, has been routinely used in various procedures and
surgeries. It has a fast onset of action (within 30-60 seconds), a short half life (1.8-4.1
minutes) but a narrow therapeutic window. The current package insert of propofol states that
only persons trained in the administration of general anesthesia should administer propofol
and these physicians should not be involved in the procedure so that patients can be
continuously and properly monitored due to the risk of respiratory depression. No deaths
associated with propofol sedation have been reported since it was first introduced in
gastrointestinal endoscopy in the mid 1980. However, need for mechanical ventilation as a
result of propofol sedation has been reported. In a number of small trials propofol was
shown to have a superior recovery profile following various endoscopic procedures including
gastroscopy, colonoscopy and endoscopic retrograde cholangiopancreatography (ERCP). Indeed,
propofol sedation is now used routinely in elective adult procedures in some centers.
However, the lower cost of recovery is offset by the need for an anesthesiologist.
Therefore, the use of propofol sedation is limited to selected endoscopic procedures or
patients.
Although a number of small randomized trials have explored the efficacy of propofol
sedation, the evidence is not definitive. Thus we conducted this study to determine if
propofol sedation leads to shorter recovery times in elective outpatient colonoscopy
compared to usual care.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03399019 -
Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia
|
N/A | |
Completed |
NCT03220880 -
Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
|
||
Recruiting |
NCT04820205 -
Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children
|
N/A | |
Recruiting |
NCT04549623 -
End-Tidal Carbon Dioxide Monitoring Device for Sedation During Endoscopic Ultrasonography
|
N/A | |
Recruiting |
NCT04822064 -
Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation
|
N/A | |
Completed |
NCT01001533 -
Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation
|
N/A | |
Completed |
NCT01527903 -
A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit
|
Phase 4 | |
Completed |
NCT00747721 -
Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU
|
Phase 1 | |
Completed |
NCT00158873 -
Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects
|
Phase 4 | |
Terminated |
NCT00205517 -
Sedation and Psychopharmacology in Critical Care
|
N/A | |
Recruiting |
NCT04096768 -
The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation
|
Phase 3 | |
Active, not recruiting |
NCT05082623 -
The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters
|
N/A | |
Suspended |
NCT03285165 -
Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04788589 -
Sedation and Ventilator Weaning Protocol in PICU
|
N/A | |
Completed |
NCT03425474 -
Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy
|
Phase 3 | |
Recruiting |
NCT06061159 -
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
|
Phase 4 | |
Completed |
NCT06449365 -
Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy
|
Phase 4 | |
Completed |
NCT02171910 -
Doxapram as an Additive to Propofol Sedation in Sedation for ERCP
|
Phase 4 | |
Completed |
NCT02211118 -
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
|
Phase 4 | |
Completed |
NCT01694745 -
EUROpean Pain Audit In Neonates
|
N/A |